Literature DB >> 23239038

Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis.

Shereem Mohamed Olama1, Mohammed Mohamed Elarman.   

Abstract

The role of paraoxonase (PON) and arylesterase (ARE) in the pathogenesis of inflammatory arthritis has been investigated, and their serum levels have been evaluated, but clinical study concerning PON1 and ARE and ankylosing spondylitis (AS) is little reported in literature. The aim of this study was to investigate PON1 and ARE activities in AS in comparison with healthy persons and their relation with the disease activity parameters. 35 AS patients and 35 healthy controls (matched for age and sex) participated. Disease activity of AS patients was assessed clinically according to the Bath AS disease activity index, and AS functional impairment was assessed using the Bath AS Functional Index. Serum samples were collected from all subjects to evaluate serum PON1, ARE activities, and lipid profile. The mean serum triglycerides, total cholesterol, and low density lipoprotein (LDL) were significantly higher in the AS patients than in controls, while the high-density lipoprotein (HDL) is significantly lower in the AS patients than controls. Serum PON1 and ARE activities were significantly lower in AS patients than in controls, while malondialdehyde (MDA) was significantly higher. AS patients with active disease had significantly higher serum triglycerides, total cholesterol, LDL and MDA while lower HDL, PON1 and ARE than those with no active AS. Decrease in the PON1/ARE activity leading to generation of oxidative stress may play an important role in the pathogenesis of AS. Moreover, it seems that activity of PON1/ARE in patients with AS is strictly correlated with the activity of the inflammatory process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23239038     DOI: 10.1007/s00296-012-2591-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  35 in total

Review 1.  Spondyloarthropathies.

Authors:  Rajesh K Kataria; Lawrence H Brent
Journal:  Am Fam Physician       Date:  2004-06-15       Impact factor: 3.292

2.  Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids.

Authors:  S T Reddy; D J Wadleigh; V Grijalva; C Ng; S Hama; A Gangopadhyay; D M Shih; A J Lusis; M Navab; A M Fogelman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-04       Impact factor: 8.311

3.  Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis.

Authors:  Gulden Baskol; Huseyin Demir; Mevlut Baskol; Eser Kilic; Filiz Ates; Derya Kocer; Sabahattin Muhtaroglu
Journal:  Clin Biochem       Date:  2005-10       Impact factor: 3.281

4.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Authors:  M Aviram; M Rosenblat; C L Bisgaier; R S Newton; S L Primo-Parmo; B N La Du
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

5.  Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease.

Authors:  Zehra Serdar; Kemal Aslan; Melahat Dirican; Emre Sarandöl; Dilek Yeşilbursa; Akýn Serdar
Journal:  Clin Biochem       Date:  2006-04-05       Impact factor: 3.281

Review 6.  Assays for oxidative stress and antioxidant status: applications to research into the biological effectiveness of polyphenols.

Authors:  Andrew R Collins
Journal:  Am J Clin Nutr       Date:  2005-01       Impact factor: 7.045

7.  Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response.

Authors:  K R Feingold; R A Memon; A H Moser; C Grunfeld
Journal:  Atherosclerosis       Date:  1998-08       Impact factor: 5.162

8.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

9.  Serum paraoxonase activity decreases in rheumatoid arthritis.

Authors:  Noriyasu Tanimoto; Yoshitaka Kumon; Tadashi Suehiro; Susumu Ohkubo; Yukio Ikeda; Koji Nishiya; Kozo Hashimoto
Journal:  Life Sci       Date:  2003-05-09       Impact factor: 5.037

10.  Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis.

Authors:  Salih Ozgocmen; Sadik Sogut; Ozge Ardicoglu; Ersin Fadillioglu; Irfan Pekkutucu; Omer Akyol
Journal:  Rheumatol Int       Date:  2003-06-17       Impact factor: 2.631

View more
  3 in total

1.  Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology.

Authors:  Monika Czókolyová; Anita Pusztai; Edit Végh; Ágnes Horváth; Anita Szentpéteri; Attila Hamar; Szilvia Szamosi; Katalin Hodosi; Andrea Domján; Sándor Szántó; György Kerekes; Ildikó Seres; Mariann Harangi; György Paragh; Éva Szekanecz; Zoltán Szekanecz; Gabriella Szűcs
Journal:  Biomolecules       Date:  2021-10-18

2.  Causal relationships between rheumatism and dyslipidemia: A two-sample Mendelian randomization study.

Authors:  Guangyang Zhang; Yuanqing Cai; Jialin Liang; Jianan Zhang; Zhaopu Jing; Leifeng Lv; Rupeng Zhang; Jidong Song; Xiaoqian Dang; Qichun Song
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-31       Impact factor: 6.055

3.  Evaluation of serum thiol/disulfide homeostasis in patients with ankylosing spondylitis by a novel method.

Authors:  Rabia Aydogan Baykara; Ayca Tuzcu; Ahmet Omma; Gunseli Karaca Acet; Erdal Dogan; Almila Aydin; Medine Cumhur Cure; Erkan Cure; Adem Kucuk; Ozcan Erel
Journal:  North Clin Istanb       Date:  2018-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.